Showing 1 - 10 of 729
We consider a discriminatory pricing and service differentiation model where: a)state physicians exploit their monopoly position and adjust quality to the unofficial payment made, and b)patients, perceiving state provision as poor, pay unofficially to improve it. Applying OLS and probit analysis...
Persistent link: https://www.econbiz.de/10005022096
This paper investigates the determinants of firm survival and growth in Slovenia, a country in transition from a plan to a market economy. Firm growth (measured using employment) and firm survival (the probability of remaining in activity) are estimated using firm level data for the years 1994...
Persistent link: https://www.econbiz.de/10005590831
In this paper I model the demand for and supply of elective surgery using a modified Hotelling framework in which waiting time, money and distance costs are determinants of the demand for hospital care. Hospitals compete with each other by varying supply and hence their waiting times. I consider...
Persistent link: https://www.econbiz.de/10005524000
The number of firms and their size are analysed for the Slovenian manufacturing sector on the basis of the firm-level evidence of the Business Register of Slovenia virtually representing all the firms in activity. A remarkable difference is found between the number of the registered...
Persistent link: https://www.econbiz.de/10005538980
This article investigates entry and exit in Slovenian manufacturing for the period 1994-2000 using OLS and panel data fixed and random-effects estimations. Private ownership is associated with higher rates of firm exit, suggesting that this ownership structure is related to a higher risk of...
Persistent link: https://www.econbiz.de/10005471805
This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...
Persistent link: https://www.econbiz.de/10011109548
This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...
Persistent link: https://www.econbiz.de/10010584038
In this paper we compare the role of internal finance on the growth of firms between a leading transition country, Slovenia and an established market economy, Belgium. We find that firms in Slovenia are more sensitive to internal financing constraints than their Belgian counterparts. This would...
Persistent link: https://www.econbiz.de/10005590798
In this paper we compare the role of internal finance on the growth of firms between a leading transition country, Slovenia and an established market economy, Belgium. We find that firms in Slovenia are more sensitive to internal financing constraints than their Belgian counterparts....
Persistent link: https://www.econbiz.de/10005684663
Although there are no traditional markets and money prices in the public sector, consumers and providers may respond to signals of organisational performance. We present a simple dynamic model of the demand and supply for elective surgery in the UK National Health Service in which waiting time...
Persistent link: https://www.econbiz.de/10005564520